NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CEO George Lawrence Mikan III sold 13,180 shares of the firm’s stock in a transaction on Wednesday, March 12th. The stock was sold at an average price of $6.93, for a total transaction of $91,337.40. Following the completion of the sale, the chief executive officer now owns 297,790 shares in the company, valued at approximately $2,063,684.70. The trade was a 4.24 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.
George Lawrence Mikan III also recently made the following trade(s):
- On Monday, March 10th, George Lawrence Mikan III sold 1,604 shares of NeueHealth stock. The stock was sold at an average price of $7.06, for a total value of $11,324.24.
- On Friday, March 7th, George Lawrence Mikan III sold 26,660 shares of NeueHealth stock. The shares were sold at an average price of $7.19, for a total value of $191,685.40.
- On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total transaction of $233,079.34.
- On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The shares were sold at an average price of $4.18, for a total transaction of $70,236.54.
NeueHealth Price Performance
Shares of NEUE opened at $6.75 on Friday. NeueHealth, Inc. has a one year low of $3.79 and a one year high of $7.66. The company has a market cap of $55.96 million, a PE ratio of -0.13 and a beta of 0.56. The firm has a 50-day moving average of $7.30 and a 200-day moving average of $6.00.
Hedge Funds Weigh In On NeueHealth
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada decreased their target price on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a research report on Monday, December 9th.
Get Our Latest Research Report on NEUE
NeueHealth Company Profile
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Further Reading
- Five stocks we like better than NeueHealth
- Investing in Construction Stocks
- 3 Undervalued Stocks You Can Buy at a Discount Now
- What is MarketRank™? How to Use it
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- 3 Small Caps With Big Return Potential
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.